ARCA biopharma Inc (ABIO)
3.615
+0.16
(+4.78%)
USD |
NASDAQ |
Apr 23, 16:00
3.615
0.00 (0.00%)
After-Hours: 16:37
ARCA biopharma Cash from Investing (TTM): 0.00 for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | -0.002M |
September 30, 2022 | -0.009M |
June 30, 2022 | -0.023M |
March 31, 2022 | -0.039M |
December 31, 2021 | -0.043M |
September 30, 2021 | -0.049M |
June 30, 2021 | -0.035M |
March 31, 2021 | -0.022M |
December 31, 2020 | -0.019M |
September 30, 2020 | -0.008M |
June 30, 2020 | -0.01M |
March 31, 2020 | -0.007M |
December 31, 2019 | -0.004M |
September 30, 2019 | -0.002M |
June 30, 2019 | -0.003M |
March 31, 2019 | -0.003M |
December 31, 2018 | 3.046M |
September 30, 2018 | 7.795M |
June 30, 2018 | 6.866M |
March 31, 2018 | 12.97M |
December 31, 2017 | 12.93M |
Date | Value |
---|---|
September 30, 2017 | 11.32M |
June 30, 2017 | 9.709M |
March 31, 2017 | -8.204M |
December 31, 2016 | -16.41M |
September 30, 2016 | -19.56M |
June 30, 2016 | -17.02M |
March 31, 2016 | -5.211M |
December 31, 2015 | -0.011M |
September 30, 2015 | -0.023M |
June 30, 2015 | -0.021M |
March 31, 2015 | -0.021M |
December 31, 2014 | -0.019M |
September 30, 2014 | -0.009M |
June 30, 2014 | -0.02M |
March 31, 2014 | -0.023M |
December 31, 2013 | -0.032M |
September 30, 2013 | -0.027M |
June 30, 2013 | -0.016M |
March 31, 2013 | -0.009M |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.004M |
June 30, 2012 | 0.005M |
March 31, 2012 | 2.006M |
December 31, 2011 | 2.006M |
September 30, 2011 | 2.262M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.049M
Minimum
Sep 2021
--
Maximum
Mar 2023
-0.0145M
Average
-0.008M
Median
Sep 2020
Cash from Investing (TTM) Benchmarks
Shockwave Medical Inc | -625.73M |
Asensus Surgical Inc | 64.51M |
Glaukos Corp | 14.10M |
Helius Medical Technologies Inc | -0.029M |
Perspective Therapeutics Inc | 24.37M |